1. A Randomized Phase I Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Recombinant Erwinia Asparaginase (JZP‐458) in Healthy Adult Volunteers. Issue 3 (23rd March 2021) Authors: Lin, Tong; Hernandez‐Illas, Martha; Rey, Andres; Jenkins, Jack; Chandula, Reddy; Silverman, Jeffrey A.; Choi, Mi Rim Journal: Clinical and translational science Issue: Volume 14:Issue 3(2021) Page Start: 870 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo®) substituted for non‐liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non‐Hodgkin lymphomas. (27th June 2013) Authors: Hagemeister, Fredrick; Rodriguez, Maria Alma; Deitcher, Steven R.; Younes, Anas; Fayad, Luis; Goy, Andre; Dang, Nam H.; Forman, Arthur; McLaughlin, Peter; Medeiros, Leonard Jeffrey; Pro, Barbara; Romaguera, Jorge; Samaniego, Felipe; Silverman, Jeffrey A.; Sarris, Andreas; Cabanillas, Fernando Journal: British journal of haematology Issue: Volume 162:Number 5(2013:Sep.) Page Start: 631 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Pharmacokinetics and pharmacodynamics of vincristine sulfate liposome injection (VSLI) in adults with acute lymphoblastic leukemia. (17th August 2013) Authors: Silverman, Jeffrey A.; Reynolds, Laurie; Deitcher, Steven R. Journal: Journal of clinical pharmacology Issue: Volume 53:Number 11(2013:Nov.) Page Start: 1139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pharmacokinetics and Safety of Momelotinib in Subjects With Hepatic or Renal Impairment. (28th December 2017) Authors: Xin, Yan; Kawashima, Jun; Weng, Winnie; Kwan, Ellen; Tarnowski, Thomas; Silverman, Jeffrey A. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 4(2018) Page Start: 522 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Population Pharmacokinetic Model Development and Simulation for Recombinant Erwinia Asparaginase Produced in Pseudomonas fluorescens (JZP‐458). Issue 12 (26th July 2021) Authors: Lin, Tong; Dumas, Todd; Kaullen, Josh; Berry, N. Seth; Choi, Mi Rim; Zomorodi, Katie; Silverman, Jeffrey A. Journal: Clinical pharmacology in drug development Issue: Volume 10:Issue 12(2021) Page Start: 1503 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Drug–Drug Interaction Profile of Presatovir. (7th February 2018) Authors: Xin, Yan; Weng, Winnie; Murray, Bernard P.; Eisenberg, Eugene J.; Chien, Jason W.; Ling, John; Silverman, Jeffrey A. Journal: Journal of clinical pharmacology Issue: Volume 58:Number 6(2018) Page Start: 771 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Relative Bioavailability, Food Effect, and Drug Interaction With Omeprazole of Momelotinib Tablet Formulation in Healthy Subjects. Issue 3 (11th October 2017) Authors: Xin, Yan; Shao, Lixin; Maltzman, Julie; Stefanidis, Dimitrios; Hemenway, Jeffrey; Tarnowski, Thomas; Deng, Wei; Silverman, Jeffrey A. Journal: Clinical pharmacology in drug development Issue: Volume 7:Issue 3(2018) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Transverse myelitis after anti‐CD19 directed CAR T cell therapy for relapsed large B cell lymphoma. Issue 1 (6th December 2021) Authors: Sheikh, Semira; Mokhtari, Sepideh; Silverman, Jeffrey A.; Reid, Kayla; Faramand, Rawan; Davila, Marco L.; Franke, Norman; Locke, Frederick L.; Jain, Michael D.; Wong, Daniel; Kuruvilla, John G. Journal: EJHaem Issue: Volume 3:Issue 1(2022) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗